Albert Reising
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
Papers in
-
- Renal cell carcinoma treatment 6
- Advanced Breast Cancer Therapies 5
- Ferroptosis and cancer prognosis 1
- Oncology 6
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 2
- Co-authors
- Martin H. Voss (7 shared papers)Robert J. Motzer (6 shared papers)A. Ari Hakimi (6 shared papers)Parul Patel (5 shared papers)Fengshen Kuo (5 shared papers)Timothy A. Chan (4 shared papers)Mahtab Marker (4 shared papers)Irina Ostrovnaya (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Research (3 papers)International Journal of Cancer (2 papers)The Lancet Oncology (2 papers)European Journal of Cancer (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Albert Reising
18 papers receiving 589 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 149
- Pulmonary and Respiratory Medicine 312
- Oncology 170
- Molecular Biology 192
- Epidemiology 80
Countries citing papers authored by Albert Reising
This map shows the geographic impact of Albert Reising's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Reising with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Reising more than expected).
Fields of papers citing papers by Albert Reising
This network shows the impact of papers produced by Albert Reising. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Reising. The network helps show where Albert Reising may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Reising, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 157 | |
| 2 | 2019 | 129 | |
| 3 | 2018 | 107 | |
| 4 | 2018 | 55 | |
| 5 | 2000 | 44 | |
| 6 | 2018 | 31 | |
| 7 | 2021 | 19 | |
| 8 | Modulation of marrow proliferation and chemosensitivity by tumor-produced cytokines from syngeneic pancreatic tumor lines. | 2002 | 11 |
| 9 | 2022 | 8 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 6 | |
| 12 | 2011 | 6 | |
| 13 | 1999 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2018 | 3 | |
| 16 | 2000 | 3 | |
| 17 | 2019 | 1 | |
| 18 | 2000 | 1 | |
| 19 | 2023 | 0 |
About Albert Reising
Albert Reising is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 19 papers that have together received 598 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer Genomics and Diagnostics (3 papers), HER2/EGFR in Cancer Research (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Ferroptosis and cancer prognosis (1 paper) and Chemotherapy-induced cardiotoxicity and mitigation (1 paper). The work is most often cited by research in Cancer Research (149 citations), Pulmonary and Respiratory Medicine (312 citations), Oncology (170 citations), Molecular Biology (192 citations) and Epidemiology (80 citations). Albert Reising has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Martin H. Voss, Robert J. Motzer, A. Ari Hakimi, Parul Patel, Fengshen Kuo, Timothy A. Chan, Mahtab Marker, Irina Ostrovnaya, Alejandro Sánchez and Lynda Vuong. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, International Journal of Cancer, The Lancet Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.